Enlightenment Research, LLC Agios Pharmaceuticals, Inc. Transaction History
Enlightenment Research, LLC
- $0
- Q4 2022
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
208Shares Held
60MCall Options Held
365KPut Options Held
457K-
Farallon Capital Management LLC San Francisco, CA5.59MShares$239 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$238 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$199 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.01MShares$171 Million1.84% of portfolio
-
State Street Corp Boston, MA3.14MShares$134 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.34B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...